# Acadia Pharmaceuticals Inc: Form 8-K, filed Feb 26, 2025

- Company: [Acadia Pharmaceuticals Inc](/companies/acad.md) (CIK 1070494)
- Form: 8-K
- Filed: 2025-02-26
- Accepted by EDGAR: Feb 26, 2025, 16:15 ET
- Period: 2025-02-26
- Accession: 0000950170-25-027759
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1070494/000095017025027759/acad-20250226.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1070494/000095017025027759/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1070494/000095017025027759/acad-20250226.htm

Filed Feb 26, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-027759. Last ingested by Listed: Oct 30, 2026, 20:22 ET. No prices; not investment advice.